Aramark [ARMK] vs Cintas [CTAS] Detailed Stock Comparison

Aramark

NYSE
Loading...

Cintas Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Aramark wins in 6 metrics, Cintas Corporation wins in 15 metrics, with 0 ties. Cintas Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Aramark Cintas Corporation Better
P/E Ratio (TTM) 38.80 36.93 Cintas Corporation
Price-to-Book Ratio 3.78 14.59 Aramark
Debt-to-Equity Ratio 203.42 60.94 Cintas Corporation
PEG Ratio -5.17 3.83 Cintas Corporation
EV/EBITDA 13.73 25.01 Aramark
Profit Margin (TTM) 1.69% 17.57% Cintas Corporation
Operating Margin (TTM) 4.50% 23.22% Cintas Corporation
EBITDA Margin (TTM) 4.50% 23.22% Cintas Corporation
Return on Equity 10.04% 41.30% Cintas Corporation
Return on Assets (TTM) 4.01% 15.94% Cintas Corporation
Free Cash Flow (TTM) $431.80M $1.76B Cintas Corporation
Dividend Yield 1.08% 1.10% Cintas Corporation
1-Year Return 31.80% -24.39% Aramark
Price-to-Sales Ratio (TTM) 0.65 6.34 Aramark
Enterprise Value $18.29B $72.61B Cintas Corporation
EV/Revenue Ratio 0.97 6.59 Aramark
Gross Profit Margin (TTM) 8.61% 50.98% Cintas Corporation
Revenue per Share (TTM) $71 $27 Aramark
Earnings per Share (Diluted) $1.19 $4.73 Cintas Corporation
Beta (Stock Volatility) 1.14 1.01 Cintas Corporation
Short % of Float 4.43% 3.33% Cintas Corporation

Aramark vs Cintas Corporation Stock Performance Analysis

Loading Price Chart...

ARMK
CTAS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Aramark-1.14%0.34%19.56%31.03%42.39%46.36%
Cintas Corporation0.81%2.86%4.69%-13.31%-5.41%-5.50%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Aramark31.80%86.25%105.62%122.32%210.17%210.17%
Cintas Corporation-24.39%42.25%94.50%621.09%2,070.60%1,524.86%

Performance & Financial Health Analysis: Aramark vs Cintas Corporation

MetricARMKCTAS
Market Information
Market Cap i$12.16B$71.06B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,845,4741,878,162
90 Day Avg. Volume i2,548,4412,537,417
Last Close$53.54$174.72
52 Week Range$35.07 - $54.57$161.16 - $229.24
% from 52W High-1.89%-23.78%
All-Time High$54.57 (Jun 02, 2026)$229.24 (Jun 06, 2025)
% from All-Time High-1.89%-23.78%
Growth Metrics
Quarterly Revenue Growth0.06%0.09%
Quarterly Earnings Growth-0.09%0.08%
Financial Health
Profit Margin (TTM) i0.02%0.18%
Operating Margin (TTM) i0.05%0.23%
Return on Equity (TTM) i0.10%0.41%
Debt to Equity (MRQ) i203.4260.94
Cash & Liquidity
Book Value per Share (MRQ)$12.21$11.97
Cash per Share (MRQ)$1.71$0.46
Operating Cash Flow (TTM) i$725.99M$2.21B
Levered Free Cash Flow (TTM) i$190.13M$1.51B
Dividends
Last 12-Month Dividend Yield i1.08%1.10%
Last 12-Month Dividend i$0.44$2.13

Valuation & Enterprise Metrics Analysis: Aramark vs Cintas Corporation

MetricARMK (Apr 26, 2026)CTAS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i38.8036.93
Forward P/E i17.6432.20
PEG Ratio i-5.173.83
Price to Sales (TTM) i0.656.34
Price to Book (MRQ) i3.7814.59
Market Capitalization
Market Capitalization i$12.16B$71.06B
Enterprise Value i$18.29B$72.61B
Enterprise Value Metrics
Enterprise to Revenue i0.976.59
Enterprise to EBITDA i13.7325.01
Risk & Other Metrics
Beta i1.141.01
Book Value per Share (MRQ) i$12.21$11.97

Financial Statements Comparison: Aramark vs Cintas Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricARMK (2025)CTAS (2025)
Revenue/Sales i18.51B10.34B
Cost of Goods Sold i16.96B5.17B
COGS % of Revenue i91.6%50.0%
Gross Profit i1.55B5.17B
Gross Margin i8.4%50.0%
Research & Development iN/AN/A
Operating Income (EBIT) i791.85M2.36B
Operating Margin i4.3%22.8%
EBITDA i1.29B2.86B
EBITDA Margin i7.0%27.7%
Pre-Tax Income i430.46M2.26B
Pre-Tax Income % of Revenue i2.3%21.9%
Income Tax i103.59M451.92M
Income Tax % of Revenue i0.6%4.4%
Net Income (Profit) i326.87M1.81B
Profit Margin i1.8%17.5%

Balance Sheet & Liquidity Metrics

MetricARMK (2025)CTAS (2025)
Cash & Equivalents i639.10M263.97M
Total Current Assets i3.52B3.44B
Total Current Assets % of Revenue i19.0%33.2%
Total Current Liabilities i3.55B1.64B
Total Current Liabilities % of Revenue i19.2%15.9%
Long-Term Debt i5.63B2.60B
Long-Term Debt % of Revenue i30.4%25.2%
Total Shareholders Equity i3.16B4.68B
Retained Earnings i453.28M11.80B
Retained Earnings % of Revenue i2.4%114.1%
Property, Plant & Equipment i1.27B3.50B

Cash Flow Statement Comparison

MetricARMK (2025)CTAS (2025)
Operating Cash Flow i858.26M2.27B
Operating Cash Flow % of Revenue i4.6%22.0%
Capital Expenditures i-466.57M23.97M
Free Cash Flow i431.80M1.76B
FCF Margin i2.3%17.0%
Debt Repayment i-1.92B-450.00M
Common Stock Repurchase i-169.83M-934.80M

Short Interest & Institutional Ownership Analysis

MetricARMKCTAS
Shares Short i11.58M9.98M
Short Ratio i4.953.80
Short % of Float i4.43%3.33%
Shares Outstanding i262.82M400.02M
Float Shares i261.28M342.08M
% Held by Insiders i0.57%14.97%
% Held by Institutions i99.34%67.80%
% Held by Public i0.09%17.23%

Dividend Analysis & Yield Comparison: Aramark vs Cintas Corporation

MetricARMKCTAS
Last 12-Month Dividend i$0.44$2.13
Last 12-Month Dividend Yield i1.08%1.10%
3-Year Avg Annual Dividend i$0.39$1.62
3-Year Avg Dividend Yield i0.28%0.22%
3-Year Total Dividends i$1.18$4.85
Ex-Dividend DateFeb 18, 2026Feb 13, 2026